The Cliches of R&D Day
Executive Summary
Attend any Big Pharma R&D day and you'll hear at least two common themes. First, that the development group has improved NDA submission timelines so dramatically that all of its drugs are moving from clinic to market faster than the average in the industry. And second, that the company's research focuses on the innovative--usually on the root causes, not symptomatic relief--of diseases for which there are at best inadequate treatments. We're not sure that either one of these notions can be swallowed undiluted.